Introduction
Non-invasive visualization of small vessel structures has been difficult due to insufficient contrast between small vessels and background tissue, and limited spatial resolution of MRI. Here, we present a method to non-invasively visualize small vascular structures in-vivo, in live animals using novel contrast agents combined with fast, high resolution image encoding methods.
Purpose
To evaluate the use of 1) the FeCo-Core/Graphitic-Carbon-Shell nanocrystal contrast agent [1] and 2) the high resolution encoding enabled by 3D spiral acquisition and small surface coils for the visualization of microvasculature in-vivo.
Methods
Normal and stenosis induced white rabbits with body weight of ~4 kg were first catheterized in the ear vein. Through the catheter, 9.6 cc of 5 mM concentration FeCo nanocrystal contrast agent was injected followed by 1 cc of saline injection. Immediately before and after the injection, a small volume covered by a 1 inch custom made surface coil was imaged using spectral-spatial excitation and 3D spiral readout. The spatial resolution was 78 × 78 × 500 um 3 with volume coverage of 4 × 4 × 1 cm 3 . The scan time was 2 min 40 sec for a single volume and the scan was repeated 9 times over 24 min to improve SNR. A whole body volume scan using a fat-saturated 3D SPGR sequence was also performed using a standard GE head coil 1 hour before and after the injection. All the experiments were conducted using a GE 1.5 T EXCITE whole body system with a maximum gradient of 40 mT/m and maximum slew rate of 150 T/m/s.
Results
The FeCo nanocrystal contrast agent's ability to produce high enhancement with 0.2 mM blood concentration which is 10% of Gd (Magnevist) dosage is demonstrated in Fig. 1 . Enhancement factor of 9 is achieved (Figure 1b,  c) as expected from the relaxivity parameters (Figure 1a) . The aortic stenosis can also be clearly observed in Fig. 1b . With this strong enhancement and high resolution acquisition, small vessels down to 78 um in diameter were successfully visualized in-vivo ( Figure. 2b ).
Conclusion
The FeCo contrast agent provides several advantages for high resolution vessel imaging; strong relaxivity, relatively long circulation time compared to conventional Gd based contrast agent, and small nano-scale size. These properties allow sufficient contrast in the small vessels for a long enough time to acquire high resolution images. The high resolution 3D spiral imaging technique combined with this FeCo contrast agent demonstrates great potential to visualize microvasculature in-vivo. The relaxivity parameters of various contrast agents indicate that with the SPGR acquisition, 0.2 mM blood concentration can produce 9 fold signal enhancement with the FeCo nanocrystal based contrast agent (a) Figure 1 The relaxivity parameters of various contrast agents indicate that with the SPGR acquisition, 0.2 mM blood concentration can produce 9 fold signal enhancement with the FeCo nanocrystal based contrast agent (a). The predictions are confirmed in (b), (c) and (b) also shows a nice depiction of the aortic stenosis.
